Glycyrrhizic acid CAS: 1405-86-3

CAS NO: 1405-86-3
Glycyrrhizic acid
Chemical Name: Glycyrrhizic acid
Molecular Formula: C42H62O16
Formula Weight: 822.94
CAS No.: 1405-86-3
Description Review
Description

Glycyrrhizic acid is a triterpenoid compound that is present in the roots of licorice (Glycyrrhiza glabra), a medicinal plant commonly used in traditional medicine. Glycyrrhizic acid has gained much attention over recent years due to its potential health benefits, including anti-inflammatory, antioxidant, and hepatoprotective effects.

Chemical name:

The chemical name of Glycyrrhizic acid is 3-O-{β-D-glucopyranosyl-(1→2)-[β-D-glucopyranosyl-(1→3)]-α-L-arabinopyranosyl}oleanolic acid.

Molecular formula:

The molecular formula of Glycyrrhizic acid is C42H62O16.

Formula weight:

The formula weight of Glycyrrhizic acid is 822.93 g/mol.

CAS No:

The CAS number of Glycyrrhizic acid is 1405-86-3.

Top ten keywords from Google and Synonyms:

  1. Anti-inflammatory
  2. Antioxidant
  3. Hepatoprotective
  4. Traditional medicine
  5. Licorice root
  6. Skin care
  7. Immune system
  8. Cancer prevention
  9. Ulcer healing
  10. Diabetes

Synonyms of Glycyrrhizic acid include Glycyrrhizin, Liquiritin, Glycyrrhizinic acid, and 18-β-Glycyrrhetinic acid 3-O-β-D-glucuronide.

Health benefits of this product:

Glycyrrhizic acid has been reported to have various health benefits, including its ability to reduce inflammation, act as an antioxidant, and protect against liver diseases.

Anti-inflammatory: Glycyrrhizic acid possesses potent anti-inflammatory properties, which can help alleviate inflammation-related conditions such as arthritis and asthma.

Antioxidant: Glycyrrhizic acid acts as an antioxidant by neutralizing harmful free radicals in the body, which can help prevent oxidative stress-related illnesses such as cancer, cardiovascular disease, and neurodegenerative disorders.

Hepatoprotective: Glycyrrhizic acid has been shown to have hepatoprotective effects by reducing liver enzyme levels, improving liver function, and protecting against liver damage.

Potential effects:

In addition to its health benefits, Glycyrrhizic acid may have other potential effects. For example, it has been reported to have ulcer-healing properties, making it beneficial for individuals with gastric ulcers. It may also have skin care benefits, such as reducing hyperpigmentation and improving skin hydration.

Product mechanism:

The exact mechanism of action of Glycyrrhizic acid is not fully understood, but it is believed to exert its effects through multiple pathways. For example, it may activate certain signaling pathways involved in cell growth and differentiation or inhibit enzymes involved in inflammation and oxidative stress.

Safety:

Glycyrrhizic acid is generally considered safe when consumed in moderate amounts. However, high doses may cause hypertension, hypokalemia, edema, and other adverse effects. Individuals with hypertension, heart disease, or kidney disease should avoid Glycyrrhizic acid.

Side effects:

Glycyrrhizic acid is generally well-tolerated, but some individuals may experience side effects, especially at high doses. These can include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. Allergic reactions are also possible, although rare.

Dosing information:

There is no standard dosing recommendation for Glycyrrhizic acid as its optimal dose may vary depending on the individual, the condition being treated, and the form in which it is consumed. However, most studies have used doses ranging from 100 to 900 mg per day.

Conclusion:

Glycyrrhizic acid is a natural product with numerous potential health benefits, including its ability to reduce inflammation, act as an antioxidant, and protect against liver diseases. Its safety profile is generally good when consumed in moderation, and it may offer additional benefits such as ulcer-healing and skin care effects. However, more research is needed to fully understand its mechanisms of action and optimal dosing strategies. Overall, Glycyrrhizic acid is a promising compound that deserves further investigation for its potential therapeutic applications

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code